PQQ, Pyrroloquinoline quinone
This is where Inno Shred GLP-1 steps inby boosting your bodys natural GLP-1 production, it fights against hunger, reduces food cravings, and supports fat burning
Electrolytes don't block nausea the way anti-emetic medications do
Your doctor should know if you have a history of: Pancreatitis (acute or chronic)both medications carry warnings about pancreatitis risk Severe gastrointestinal disease , including gastroparesis, which may be exacerbated by GLP-1-based therapies Renal impairment sitagliptin requires dose adjustment based on eGFR, while tirzepatide does not require dose adjustment, though caution is advised with dehydration Thyroid disease Mounjaro's UK SmPC notes that rodent studies showed an increased incidence of thyroid C-cell tumours, though the relevance to humans is unknown
Possible monitoring points include unknown long-term safety, limited human data for routine wellness use, contamination risk from non-medical sources, and unpredictable effects
